I-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scans

dc.contributor.authorAkgun, A.
dc.contributor.authorYazici, B.
dc.contributor.authorErdim, O.
dc.contributor.authorOzcan, Z.
dc.contributor.authorOzkilic, H.
dc.date.accessioned2019-10-27T19:17:27Z
dc.date.available2019-10-27T19:17:27Z
dc.date.issued2006
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS330en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS330en_US
dc.identifier.urihttps://hdl.handle.net/11454/38382
dc.identifier.volume33en_US
dc.identifier.wosWOS:000202967401198en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imagingen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleI-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scansen_US
dc.typeConference Objecten_US

Dosyalar